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ABSTRACT
The DNA-binding domains (DBDs) of class I steroid
receptors—androgen, glucocorticoid, progesterone
and mineralocorticoid receptors—recognize a
similar cis-element, an inverted repeat of 50-AGAA
CA-30 with a 3-nt spacer. However, these receptors
regulate transcription programs that are largely
receptor-specific. To address the role of the DBD
in and of itself in ensuring specificity of androgen
receptor (AR) binding to chromatin in vivo, we
used SPARKI knock-in mice whose AR DBD has
the second zinc finger replaced by that of the gluco-
corticoid receptor. Comparison of AR-binding
events in epididymides and prostates of wild-type
(wt) and SPARKI mice revealed that AR achieves se-
lective chromatin binding through a less stringent
sequence requirement for the 30-hexamer. In par-
ticular, a T at position 12 in the second hexamer is
dispensable for wt AR but mandatory for SPARKI
AR binding, and only a G at position 11 is highly
conserved among wt AR-preferred response
elements. Genome-wide AR-binding events agree
with the respective transcriptome profiles, in that
attenuated AR binding in SPARKI mouse epididymis
correlates with blunted androgen response in vivo.
Collectively, AR-selective actions in vivo rely on
relaxed rather than increased stringency of cis-
elements on chromatin. These elements are, in
turn, poorly recognized by other class I steroid
receptors.
INTRODUCTION
Androgens mediate the effects of male sex steroids
through the androgen receptor (AR) that regulates expres-
sion of androgen-dependent genes by binding to cis-
elements in the regulatory regions of target genes. The
DNA-binding domain (DBD) of class I steroid recep-
tors—AR, glucocorticoid receptor (GR), progesterone
receptor (PR) and mineralocorticoid receptor (MR)—is
highly conserved. They all recognize a similar palindromic
response element that comprises an inverted repeat of the
50-AGAACA-30 hexamer with a 3-nt spacer, usually
termed as a canonical androgen/glucocorticoid response
element (ARE/GRE) (1). The ﬁrst hexamer is highly
conserved and represents the high-afﬁnity site for
receptor interaction because mutations in this core, as
opposed to the second one, have a strong impact on
receptor binding and reporter gene responsiveness, as
shown by in vitro assays (2). In transient transfection ex-
periments, AR, GR, PR and MR are all capable of
binding to the canonical ARE/GRE and inducing expres-
sion of reporter genes driven by the canonical sequence
(3). Moreover, genome-wide analyses using chromatin
immunoprecipitation (ChIP) coupled with high-
throughput sequencing (ChIP-seq) experiments have
shown that AR and GR bind to shared loci on native
chromatin (4–6). One-half of the AR cistrome overlaps
with that of GR in LNCaP-1F5 prostate cancer cells,
and ligand-occupied GR is able to modulate the AR
pathway (5). These results present a biological enigma:
how are speciﬁc responses to cognate ligands of class I
steroid receptors ensured in cells that express multiple re-
ceptors at the same time.
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One potential explanation for speciﬁc responses to class
I steroid receptor ligands is subtle differences in the
cis-elements that receptor DBDs recognize on chromatin.
Selective AREs resembling direct repeats of the 50-AGAA
CA-30 hexamer are not recognized by GR or MR in vitro
(3,7,8). A chimeric AR, in which the second zinc ﬁnger of
the DBD is replaced by that of GR, possesses signiﬁcantly
attenuated afﬁnity for selective AREs in transient trans-
fection experiments and in vitro binding assays, whereas
transactivation by the chimeric receptor via the classical
ARE/GREs is similar to or better than that by wild-type
(wt) AR (9). A transgenic mouse line with the same AR to
GR switch in the second zinc ﬁnger of the DBD, dubbed
SPARKI (speciﬁcity-affecting AR knock-in) mice,
has smaller reproductive organs and reduced fertility
compared with wt littermates, although androgen-depend-
ent anabolic parameters, such as body weight and muscle
strength, are unaffected (9). SPARKI males show reduced
sperm count and impaired sperm maturation, suggesting
defective function of the epididymis, a highly androgen-
responsive reproductive organ (10).
SPARKI mice provide an excellent in vivo model system
to investigate the importance of DBD structure in and of
itself in setting apart genome-wide androgen-speciﬁc re-
sponses from those potentially regulated by glucocortic-
oids as well. Here, we compared AR-binding events and
transcription programs in epididymides and prostates of
wt and SPARKI male mice to delineate potential genome-
wide rules behind androgen-selective responses. Our
results show that, counter-intuitively, AR selectivity is
achieved by relaxed rather than tightened cis-element
stringency at chromatin binding sites which, in turn, at-
tenuates binding of other class I steroid receptors to these
cis-elements.
MATERIALS AND METHODS
Mice and hormone treatments
All the experiments were carried out using 12-week-old adult
male mice of C57BL/6 strain. SPARKI knock-in mice have
been described previously (9). Wt littermates were used as
controls. For ChIP assays, caput epididymides and ventral
prostates were collected from intact wt and SPARKI male
mice. For mRNA isolation, caput epididymides were har-
vested from castrated wt and SPARKI mice. Testosterone
treatment was brought about by sc Silastic implants (Silclear
Tubing; Degania Silicone, Jordan Valley, Israel) for 7 days,
corresponding to a daily dose of 23mg. Control group
received empty implants. All experimental work involving
animals was conducted with approval of the Katholieke
Universiteit Leuven ethical committee.
Chromatin immunoprecipitation
ChIP assays were performed as described previously (4) with
modiﬁcation for tissues (11). Ventral prostates from four
and caput epididymides from six wt mice and eight
SPARKI mice were pooled to yield one 500 -ml chromatin
sample. Frozen tissueswere pulverized and cross-linkedwith
1% formaldehyde for 20min at room temperature.
Formaldehyde was quenched by adding 0.125M glycine
for 5min at room temperature, followed by two washes
with ice-cold phosphate-buffered saline. The cross-linked
tissues were homogenized in hexylene glycol buffer (1 M
hexylene glycol, 0.1mM MgCl2, 5mM ethylene glycol
tetraacetic acid, 1mM PIPES, 2mM dithiothreitol, 1 pro-
teinase inhibitor cocktail; Roche Diagnostics, Indianapolis,
IN, USA) using Ultra Turrax (Ika, Staufen, Germany),
ﬁltered through nylon net (20mm), and nuclei isolated by
low-speed centrifugation. The crude nuclear pellet was re-
suspended in radioimmunoprecipitation assay buffer and
sonicated using a micro-tip sonicator (Misonix Inc.,
Farmingdale, NY, USA) to yield chromatin fragments of
100–500 bp in size. Anti-AR (12) and normal rabbit IgG
(sc-2027, Santa Cruz, Dallas, TX, USA) antibodies were
conjugated to Dynabeads (Invitrogen, Carlsbad, CA,
USA) and incubated with sonicated chromatin overnight
at 4C, followed by ﬁvewashes inLiCl buffer and incubation
at 65C overnight for reverse crosslinking.
Immunoprecipitated DNA was puriﬁed and used for quan-
titative polymerase chain reaction (qPCR) analysis. In
ChIP–qPCR, immunoprecipitated and input DNA were
ampliﬁed using SYBR Green Mastermix (Roche) and
speciﬁc primers (Supplementary Table S1), and the results
are shown as percentage of input values.
ChIP-seq library preparation
ChIP samples were processed according to Illumina’s
library preparation protocol by pooling three immunopre-
cipitates for each library (4). In brief, DNA samples were
blunt-ended, A-tailed and ligated to sequencing adapters
followed by size selection (size range 150–300 bp) on
agarose gel. Excised fragments were puriﬁed using
Qiaquick Gel Extraction kit (Qiagen GmbH, Hilden,
Germany) followed by PCR ampliﬁcation for 20 cycles.
The puriﬁed DNA was sequenced using GAII (Illumina
Inc., San Diego, CA, USA) at Biomedicum Functional
Genomics core facility. ChIP-seq reads were ﬁltered ac-
cording to Illumina’s instructions using the Illumina
chastity ﬁlter, and reads were aligned to mouse genome
(mm9) using Bowtie without any mismatches. ChIP-seq
experiments were carried out in biological duplicates.
Bioinformatics analysis
ChIP-seq peak calling and differential peak calling were
performed using MACS2 (13,14) and HOMER (15) algo-
rithms. The overlap analysis, tag density maps and
binding site correlation plots were performed using
Cistrome (16). The de novo motif analysis was performed
using MEME Suite (17) and HOMER motif discovery
algorithm (15). Data visualization was carried out using
Integrative Genomics Viewer (18). Gene expression
proﬁles for differentially expressed genes in whole epididy-
mis of intact wt and SPARKI mice (10) were compared
with the differentially androgen-regulated genes in caput
epididymis (11).
Electrophoretic mobility shift assay
AR and GR DBD fragments of 11 kDa in size, corres-
ponding to residues 533–637 of rat AR DBD and residues
432–533 of rat GR DBD, were expressed as glutathione
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S-transferase fusion proteins in the Escherichia coli
BL21 strain (8). The GST tag was removed by
thrombin cleavage. Double-stranded oligonucleotides
containing ARE sequences (Supplementary Table S1)
were labeled with [a-32P]dCTP by a ﬁlling-in with the
Klenow fragment of DNA polymerase. Slp-MUT and
Slp-HRE sequences have been described (3). Puriﬁed
AR DBD or GR DBD (100 ng protein) was incubated
with radiolabeled probe (20 000 cpm) in 10mM HEPES
(pH 7.9), 2.5mM MgCl2, 0.05mM ethylenediaminete-
traacetic acid, 8% glycerol, 50mM NaCl, 2.5 ng/ml
poly (dIdC), 1mM dithiothreitol and 0.05% Triton
X-100 for 20min on ice. DBD-bound and unbound
probes were separated by electrophoresis on a 4%
polyacrylamide gel. Radioactive bands were visualized
with STORM 840 PhosphorImager (Molecular
Dynamics).
Transactivation assays
HeLa cells (ATCC, Manassas, VA, USA) were cultured
in Dulbecco’s modiﬁed Eagle’s medium containing 4.5 g/l
glucose, 4mM L-glutamine, penicillin (100 IU/ml)–
streptomycin (100mg/ml) (Sigma-Aldrich, St. Louis,
MO, USA) and 10% fetal calf serum (Invitrogen). For
transactivation experiments, cells were seeded onto 96-
well plates (8000 cells/well) in Dulbecco’s modiﬁed
Eagle’s medium supplemented with 5% charcoal-
stripped serum (Sigma-Aldrich) and transfected using
GeneJuice (Novagen, Merck KGaA, Darmstadt,
Germany) with 10 ng of AR or GR expression plasmid
(19), 100 ng of luciferase reporter plasmid containing
four copies of the ARE of interest (Supplementary
Table S1) and 5 ng of b-galactosidase expression
plasmid (Stratagene, Santa Clara, CA, USA). Reporter
plasmids were generated as previously described (3). Cells
were lysed after a 24-h exposure to 10 nM
methyltrienolone (Perkin Elmer, Waltham, MA, USA)
or 10 nM dexamethasone (Sigma-Aldrich). Luciferase
and b-galactosidase activities were measured, and trans-
activation activity was calculated (20).
RNA isolation and quantitative reverse transcription PCR
Caput epididymides of wt and SPARKI mice (n=5 in
both cases) were harvested in RNALater (Qiagen) after
a 7-day treatment with testosterone or vehicle. Total
RNA was isolated using RNeasy Mini Kit (Qiagen).
cDNA synthesis was carried out from 2 mg of total RNA
with Transcriptor High Fidelity cDNA synthesis kit using
random hexamers (Roche). Quantitative reverse
transcription PCR (qRT-PCR) was performed using
SYBR Green mastermix (Roche) and normalized to 18 S
rRNA levels. Student’s t-test (P< 0.001) was used to cal-
culate the statistical signiﬁcance of differences in gene ex-
pression in wt and SPARKI mice between testosterone-
and vehicle-treated groups and between testosterone-
treated wt and SPARKI groups. The primer sequences
are provided in Supplementary Table S1.
RESULTS
Genome-wide AR-binding events in wt and SPARKI
epididymis
ChIP-seq analyses of in vivo AR-binding sites (ARBs) on
epididymal chromatin were performed in biological dupli-
cate samples. Examples of AR ChIP-seq tracks of wt and
SPARKI mice are shown in Figure 1A at two genomic loci
that are androgen-responsive in murine epididymis (11);
Fkbp5 (FK506 binding protein 5) encoding a chaperone
protein and Acox3 (acyl-coenzyme A oxidase 3) involved
in fatty acid metabolism in peroxisomes. AR occupancy is
indistinguishable at the Fkbp5 regulatory region between
wt and SPARKI mice, which agrees with the result that
Fkbp5mRNA accumulation is induced by androgen to the
same extent in epididymides of these mice (10). Sequenced
reads were aligned to mouse genome (mm9) using bowtie,
and peak calling for individual replicates was carried out
using MACS2 (13,14). Importantly, the biological repli-
cates show excellent concordance, as judged by individual
ChIP-seq tracks (Figure 1A) and by coefﬁcient values
from correlation analyses of the raw sequence data
(Figure 1B). To increase the depth of analysis, we
concatenated independent biological replicates and re-per-
formed peak calling using two different algorithms,
MACS2 and HOMER (15). The peaks called from the
two algorithms were used to compute the ﬁnal overlapping
peaks (with at least 1 nt overlap), resulting in AR
cistromes comprising 10 009 and 6446 ARBs in wt and
SPARKI epididymides, respectively (Figure 1C,
Supplementary Data sets S1 and S2).
SPARKI AR fails to recognize wt AR-preferred enhancers
Two-thirds of the SPARKI AR cistrome overlap with that
of wt mice (Figure 2A). The greater number of ARBs that
are unique to wt epididymis is explainable by the ability of
wt AR to recognize selective AREs. Because the SPARKI
AR is anticipated to recognize the canonical ARE/GRE
only, it is intriguing that there are also in vivo AR-binding
events that are favored by the SPARKI receptor
(Figure 2A). As ChIP-seq provides a quantitative assess-
ment of receptor binding across the genome, the tag
density of AR binding to a given site could be used as a
surrogate measure for the afﬁnity of the receptor to this
site. The tag density maps of AR-binding events and
average tag proﬁles in wt and SPARKI mice indicate
that the two receptors are loaded to the same extent
onto sites shared by wt AR and SPARKI AR, most
likely reﬂecting indistinguishable binding afﬁnities of the
receptors for these sites (Figure 2B and C). Overall, wt and
SPARKI ARs bind to the shared sites with 2-fold higher
afﬁnity than to non-shared sites (Figure 2C). Interestingly,
shared sites have also been reported to be the high-afﬁnity
binding loci for the estrogen receptor, when chromatin
binding events in multiple estrogen target tissues or cell
lines were compared with those with strict tissue- or cell-
type speciﬁcity (21).
The ‘uniqueness’ of wt and SPARKI AR-binding events
is relative rather than absolute, in that there are signiﬁcant
quantitative differences in the recruitment of the two ARs
4232 Nucleic Acids Research, 2014, Vol. 42, No. 7
 at H
elsinki U
niversity Library on M
ay 18, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
to these sites. Therefore, we call the two ARB groups as wt
AR-preferred and SPARKI AR-preferred sites (Figure 2B
and C). The tag density maps constructed for the wt AR-
preferred sites with a >4-fold and a 2–4-fold change over
SPARKI ARBs indicate that wt AR-binding events with
high fold changes are poorly recognized by SPARKI AR
(Figure 2B). The reverse is true for the AR-binding events
preferred by SPARKI AR; these sites are recognized less
well by wt AR (Figure 2B). The average tag proﬁles—a
more quantitative assessment of the differences—reveal
that the ARBs preferred by wt AR have tag numbers
three times higher than those of SPARKI AR at the
same sites, and the binding events preferred by SPARKI
AR have twice the number of tags over those of wt AR at
the same sites (Figure 2C). Collectively, these data indicate
that there are classes of cis-elements that wt and SPARKI
ARs recognize with dissimilar binding afﬁnities.
Examples of ChIP-seq tracks are shown in Figure 2D
with sequences at the summit of a shared AR-binding
event (50-acAGAACAgaaTGTTCTct-30) and a SPARKI
AR-preferred site (50-agAGAACAtggTGTTCCct-30).
Both possess a canonical ARE/GRE, a palindrome
of 50-AGAACA-30 with a 3-nt spacer. The example of a
cis-element preferred by wt AR is a non-canonical
ARE (Figure 2D) that bears resemblance to an imperfect
direct repeat sequence (50-gaGGAACAgggTGAACC
aa-30).
WT AR selectivity in vivo depends on relaxed cis-element
stringency
We hypothesized that genome-wide AR-binding events in
epididymides of wt and SPARKI mice will help in estab-
lishment of deﬁned rules for the cis-elements that AR rec-
ognizes on chromatin. To this end, we performed de novo
motif search analyses using MEME Suite (17) for the three
ARB categories: (i) binding sites shared by the two recep-
tors or (ii) preferred by wt AR or (iii) SPARKI AR—on
sequences comprising the top 1000 sites spanning±15 bp
around the summit of the receptor binding locus. As
expected, an inverted palindromic repeat with a 3-nt gap
resembling the canonical ARE/GRE is highly enriched
among the shared ARBs (E=3.7e-639). Interestingly, a
similar cis-element is also highly enriched among the
Figure 1. In vivo AR binding in epididymis of wt and SPARKI mice. (A) AR-binding events mapped to Fkbp5 and Acox3 loci in caput epididymis of
wt and SPARKI male mice. ChIP-seq tracks from two independent biological replicates and non-speciﬁc rabbit IgG control are shown. (B) Genome-
scale wiggle ﬁle correlation plot and correlation coefﬁcient values for AR-binding events of two independent biological replicates in epididymides of
wt and SPARKI mice. (C) The number of AR-binding peaks derived from concatenated biological replicates and using MACS2 and HOMER peak
calling algorithms. (FDR, false discovery rate).
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ARBs preferred by SPARKI AR (E=3.2e-437). In both
instances, there is a high degree of sequence conservation.
The best conserved nucleotides are a G at position 2 and a
C at position 5, followed by an A at positions 4 and 6, and
their complementary partners T, G, T and C at positions
10, 11, 12 and 14, respectively (Figure 3A).
De novo motif search analyses of the binding sites
preferred by wt AR uncovered a different cis-element
(E=1.1e-403), in which the 50 hexamer is almost identical
with that described above but separated by a 3-nt gap
from a hexamer with weak sequence conservation
(Figure 3A). This latter hexamer has a highly conserved
G at position 11, along with weak conservation for T and
C at positions 10 and 14, respectively. Importantly, the
highly conserved T at position 12 of the canonical ARE/
GRE present at the shared and SPARKI AR-preferred
sites is dispensable among the cis-elements for wt AR
binding. Thus, relaxed stringency in the cis-element
sequence—dismissal of the conserved T at position 12 in
particular—ensures selective wt AR binding to chromatin.
This result agrees with a previous mutational analysis
showing that substitution of an A with a T at this
position in a selective ARE enhances GR binding and
glucocorticoid response (2).
Wt AR-preferred and SPARKI AR-preferred binding
events were next cross-compared directly by HOMER.
This analysis revealed that 31% of the wt AR-preferred
peaks have >4-fold enrichment over those to SPARKI
AR (1721 ARBs, Supplementary Data set S3), and 21%
of the SPARKI AR-preferred peaks have >4-fold enrich-
ment over those of wt AR (414 ARBs, Supplementary Data
set S4) (Figure 3B). Importantly, <1% of the shared AR-
binding peaks show >4-fold differential enrichment,
implying an equal binding afﬁnity for wt and SPARKI
AR at the shared sites (Figure 3B). To characterize
further the nature of the cis-elements among the wt AR-
preferred ARBs, de novo motif search analysis was per-
formed on the top 500 ARBs with >4-fold difference
between wt and SPARKI AR binding peaks (Figure 3B,
uppermost and lowest lines). This analysis yielded binding
motifs for wt and SPARKI AR that are similar to those
obtained by direct de novo motif searches (cf. Figure 3A
and C). Of note, different analysis parameters, such as dif-
ferent windows around the peak summits, the use of
Figure 2. Features of the AR-binding events in epididymides of wt and SPARKI mice. (A) Area-proportional Venn diagrams of AR cistromes in
epididymis of wt and SPARKI mice. (B) Tag density maps of AR-binding events in wt and SPARKI epididymides at wt AR-preferred, shared and
SPARKI AR-preferred binding sites in a span of ±5kb. Tag density maps of AR-binding events in wt and SPARKI epididymides at wt AR-
preferred sites showing 2–4-fold or >4-fold difference in the differential enrichment analysis (wt versus SPARKI), and at SPARKI AR-preferred sites
showing 2–4-fold or >4-fold difference in SPARKI versus wt differential enrichment analysis using HOMER. (C) Average tag numbers of ARBs in a
window of ±500 bp centered around the summit of the receptor-binding site in the three AR-binding event categories: wt AR-preferred, shared and
SPARKI AR-preferred. (D) ChIP-seq track examples of AR-binding events in the three categories and the corresponding DNA sequence at the
summit of the ARBs. Fold-enrichment ratios computed from ChIP-seq peaks: Mro (wt versus SPARKI) 78-fold, Cgnl1 (wt versus SPARKI) 1.09-
fold, Olfr1082 (SPARKI versus wt) 3.3-fold.
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shufﬂed instead of top-enriched sites or different algorithms
(HOMER or MEME Suite) did not change the results of
de novo analysis. Direct ChIP–qPCR validation of 13
randomly chosen loci corresponding to AR-binding
events in the three categories conﬁrm that there are signiﬁ-
cant quantitative differences in the loading of AR onto sites
preferred either by wt AR or SPARKI AR (Figure 3D).
In vitro validation of the wt AR-preferred, SPARKI
AR-preferred and shared cis-elements
Electrophoretic mobility shift assay (EMSA) with AR
DBD and GR DBD was used to examine the speciﬁcity
of a few ARE sequences in the three categories under
in vitro conditions. Classical and selective AREs,
characterized in previous work (3), were used as
controls. The second zinc ﬁnger of SPARKI AR is iden-
tical with that of GR, and SPARKI AR-preferred and
shared sequences were bound by both AR DBD and
GR DBD (Figure 4A and B). The AREs classiﬁed by
our ChIP-seq analysis as wt AR-preferred sequences
were not recognized by GR DBD at all or with low
afﬁnity (Figure 4C). Thus, the results from EMSAs
using naked DNA and AR DBD or GR DBD agree
with those of ChIP-seq experiments carried out in a
genuine chromatin environment and with full-length
receptors.
To validate the ARB categories further, three AREs
from each group were cloned in four copies upstream of
the luciferase reporter gene and exposed in transactivation
assays in HeLa cells to methyltrienolone and dexametha-
sone for AR and GR, respectively. AR was able to
transactivate via all nine AREs, conﬁrming their func-
tional enhancer nature (Figure 4D). Importantly, GR
could transactivate only through shared and SPARKI-
preferred ARBs comprising canonical AREs but not
through wt AR-preferred ARE sequences (Figure 4E).
Differential AR-binding events are linked to differentially
expressed genes in wt and SPARKI epididymis
By examining the gene expression data from whole
epididymides of intact wt and SPARKI male mice (10),
we found 511 transcripts with higher expression in wt than
SPARKI mice (= wt-preferred genes) and 843 transcripts
with higher expression in SPARKI than wt mice (=
SPARKI-preferred genes) (fold change1.5, P< 0.05).
Even though intact male mice have physiological
androgen levels, these differentially expressed transcripts
may not all be androgen-regulated. To address this issue,
we compared the Kerkhofs et al. data set (10) with
androgen-regulated genes in caput epididymides of
castrated male mice treated for 3 days with testosterone
or vehicle (11) and identiﬁed 219 androgen-regulated tran-
scripts that are differentially expressed in intact SPARKI
versus wt mice (110 androgen upregulated and 109
androgen downregulated transcripts, Supplementary
Data set S5). Unsupervised hierarchical clustering of the
Figure 3. Sequence enrichment analysis and validation of the AR-binding events. (A) Cis-elements identiﬁed by de novo motif search for the ARBs
belonging to shared, SPARKI AR-preferred and wt AR-preferred categories. (B) Differential enrichment analysis for wt versus SPARKI and
SPARKI versus wt binding data sets by HOMER for the three categories of AR-binding events. The number of ARBs with differential enrichment
>4 and the corresponding percentage of all ARBs in each category are shown. (C) Cis-elements enriched by de novo motif analysis for the binding
peaks differentially enriched in SPARKI AR versus wt AR and in wt AR versus SPARKI AR. (D) Validation of AR-binding events by direct ChIP–
qPCR assays for the three categories. ChIP was performed from chromatin samples obtained after pooling epididymides from six wt and eight
SPARKI mice. Mean+SEM for two biological replicates are shown. In each category, 13 loci were selected for the analysis.
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219 transcripts revealed that most of the wt-preferred
genes are upregulated by androgen, whereas most of the
SPARKI-preferred genes are downregulated by androgen
exposure (Figure 5A). Importantly, the wt-preferred
androgen-regulated genes such as Rhbg, Rhbdd3, Ehd3,
Isyna1, Acat2, Ccno, Ramp3, Lcn12 and Cyp4f15 show
blunted upregulation by testosterone treatment in
SPARKI epididymis compared with wt, as judged by
mRNA accumulation (Figure 5B). Moreover, loss or at-
tenuation of AR binding at regulatory sites of the wt-
preferred genes Rhbg, Rhbdd3, Ehd3, Isyna1, Acat2 and
Ccno is observed in SPARKI epididymis compared with
wt (Figure 5C). Likewise, qRT-PCR assays conﬁrm the
differential expression of SPARKI-preferred genes in
SPARKI epididymis compared with the wt epididymis
as seen in the case of Arrdc2, Pdk2l1 and Calml3
(Figure 6A). There is greater loading of SPARKI AR
than wt AR onto the Pkd2l1 locus, but in some instances,
such as Arrdc2, there is no clear difference between wt AR
and SPARKI AR-binding events (Figure 6B). Examples
of androgen-regulated genes (Fkbp5, Acox3, Lipg, Creld2
and Kcnk1) that are stably expressed in both wt and
SPARKI epididymides are shown in Figure 6C. In
agreement with transcript accumulation, AR loading is
equal onto the respective regulatory regions in wt and
SPARKI epididymis, as exempliﬁed by Fkbp5 and
Acox3 (Figure 1A) and Lipg and Creld2 (Figure 6D).
Relaxed AR cis-element stringency is not limited to the
epididymis
To examine whether the ﬁnding on in vivo AR selectivity
also applies to another androgen target tissue, we per-
formed AR ChIP-seq on ventral prostates of SPARKI
mice and their wt littermates. Peak calling with MACS2
and HOMER identiﬁed 6693 and 5552 high-conﬁdence
AR-binding events in prostates of wt and SPARKI
mice, respectively, 3370 of which are shared by the two
receptors (Figure 7A, Supplementary Data sets S6 and
S7). SPARKI AR has low afﬁnity to wt AR-preferred
sites and wt AR to SPARKI AR-preferred sites, whereas
both receptors bind to shared sites with high afﬁnity
(Figure 7B). Of the wt AR-preferred ARBs, 1079
sites have >4-fold enrichment over SPARKI AR
(Supplementary Data set S8), and 609 SPARKI
AR-preferred sites have >4-fold enrichment over wt AR
(Supplementary Data set S9). Importantly and similar to
Figure 4. Validation of the three ARB categories by EMSAs and transactivation assays. Radiolabeled double-stranded oligonucleotides containing
the AREs were tested for binding by puriﬁed AR DBD or GR DBD. Arrows refer to free probe and arrowheads to ARE DBD complexes. Slp-MUT
and Slp-HRE are classical and selective ARE controls, respectively. (A) AREs from three SPARKI AR-preferred binding sites. (B) AREs from three
shared binding sites. (C) AREs from three AR-preferred binding sites. HeLa cells were transiently transfected with AR (D) or GR (E) expression
vector together with luciferase reporter constructs containing four copies of the putative AREs. Cells were exposed to methyltrienolone (R1881) (D)
or dexamethasone (Dex) (E) for 24 h. Results are normalized to b-galactosidase activities and presented as mean+SEM values of three biological
replicates performed in triplicate.
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epididymis, the cis-element identiﬁed by de novo motif
search among the wt AR-preferred ARBs in prostate
shows weak conservation of the second hexamer
sequence, highlighting the relaxed cis-element stringency,
with the G at position 11 being an important determinant
for selective AR binding in vivo (Figure 7C). In a manner
identical with that in epididymis, SPARKI AR-preferred
and shared ARBs are enriched in prostate for the canon-
ical ARE/GRE (Figure 7C). Examples of AR ChIP-seq
tracks at three androgen-responsive loci in murine
prostate, Pgap2, Creld2 and Slc25a30 (11) depict wt and
SPARKI AR loading onto enhancers of the three ARB
categories—wt and SPARKI AR-preferred or shared—
and show the respective ARE sequences at peak
summits (Figure 7D).
DISCUSSION
Previous work has shown that there are two types of cis-
elements that are recognized by the AR: (i) classical AREs
corresponding to the canonical ARE/GRE and recognized
by other class I steroid receptors as well, and (ii) selective
AREs recognized primarily by AR and showing features
that resemble direct repeats of the 5’-AGAACA-3’ hexamer
(3,10,22). By using genome-wide in vivo AR ChIP-seq on
epididymal and prostatic chromatin of wt and SPARKI
mice, we show in this work that the SPARKI AR fails to
bind or binds with blunted afﬁnity to sites corresponding to
selective AREs. A signiﬁcant proportion—55 and 50% of
the epididymal and prostatic AR cistromes, respectively—
comprised wt AR-preferred ARBs afﬁrming the biological
importance of selective AREs in ensuring speciﬁc AR re-
sponses. Surprisingly, the genome-wide analyses revealed
that the selectivity of AR binding over that of other class
I steroid receptors relies on relaxed rather than more strin-
gent requirement for the response element sequence.
Attenuated binding of SPARKI AR to selective AREs
was, in turn, accompanied by blunted response to andro-
gens of the corresponding genes in SPARKI mice.
The 5’ hexameric core is almost identical between canon-
ical ARE/GREs and selective AREs, and this hexamer is
suggested to be the high-afﬁnity DNA sequence for the
Figure 5. Comparison of AR-binding events and transcriptome proﬁles in wt and SPARKI epididymis. (A) Unsupervised hierarchical clustering of
transcripts that are regulated by testosterone in caput epididymis (T versus vehicle) and expressed differentially in epididymides of intact SPARKI
and wt male mice (SPARKI versus wt). (B) Relative mRNA levels, as measured by qRT-PCR, for wt-preferred androgen-regulated genes in
epididymides of castrated wt or SPARKI mice treated with testosterone or vehicle. (Mean+SEM values are shown, n=5). Statistically signiﬁcant
differences (P< 0.001) between testosterone-treated wt and SPARKI mice are indicated by stars above the lines, and statistically signiﬁcant differences
(P< 0.001) between vehicle- and testosterone-treated groups are depicted by asterisks above the black bar (testosterone) adjacent to the corresponding
white bar (vehicle). (C) ChIP-seq tracks of six representative examples showing differences in AR loading onto genomic loci adjacent to AR-
regulated genes in wt and SPARKI epididymides.
Nucleic Acids Research, 2014, Vol. 42, No. 7 4237
 at H
elsinki U
niversity Library on M
ay 18, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
binding of the ﬁrst DBD (22,23). The contact of the ﬁrst
DBD to the high-afﬁnity site is assumed to lead to a con-
formational change in the receptor protein, and possibly also
in the DNA element, which subsequently facilitate binding
of the second DBD to the less conserved low-afﬁnity site
(22,23). Previous work has indicated that the 30 hexamer
of selective AREs resembles, in many instances, an imperfect
direct repeat of the 50 hexameric sequence 50-AGAACA-30
[summarized in (22)]. Our current results show why this
would be the case, in that the Gs at positions 2 and 11 are
highly conserved in the selective AREs, permitting 30
hexameric sequences that can be interpreted as being imper-
fect direct repeats. More importantly, however, selective
AREs exhibit no requirement for a T at position 12.
Genome-wide ChIP-seq experiments on several cell lines or
tissues have shown that cis-elements for GR and PR contain
a highly conserved T at this position (4–6,24–27). Thus, AR
selectivity is achieved by loosening the structural stringency
in the 30 hexameric sequence, and consequently, other class I
steroid receptors fail to bind to this element. Crystal struc-
ture studies have indicated that AR DBD has substitutions
that create higher afﬁnity for the receptor dimer interface
than that of GRDBD, and subsequently, the AR could bind
to a more diverse set of cis-elements with higher afﬁnity and
speciﬁcity than the GR (22,23). Thus, the high-afﬁnity
protein–protein binding at dimer interface rather than strin-
gent cis-element structure is important for AR selectivity
over the other class I type receptors. Other features in the
receptor structure could possibly also contribute to the dif-
ferent binding afﬁnities of AR and GR as well, as mutations
changing the amino acids in the dimerization interface did
not affect in vitro DNA-binding afﬁnities or transactivation
capabilities of the two receptors (28).
We examined in this work the role of DBD in and of
itself in assuring the selectivity of AR signaling by
comparing wt and chimeric receptors. However, speciﬁc
transcriptional outcome in vivo by steroid receptors is
inﬂuenced not only by the cis-element and its interaction
with the DBD, but also by a number of chromatin modi-
ﬁcations and divergent collaborating factors (29). Pioneer
factors are proteins capable of binding to compact chro-
matin and priming it for steroid receptor binding. In
prostate cancer cells and in normal mouse prostate, AR
binding is primed by FoxA1, and a distinct cis-element,
composed of an ARE half-site and a FoxA1 element, is
highly enriched among the AR-binding sequences (4,11).
Figure 6. AR-binding events and androgen-regulated genes of wt and SPARKI epididymis for SPARKI-preferred genes and stably expressed genes
in SPARKI versus wt conditions. (A) Relative mRNA levels, as measured by qRT-PCR, for SPARKI-preferred androgen-regulated genes in wt and
SPARKI epididymides of castrated male mice treated with vehicle or testosterone. (Mean+SEM values, n=5). Statistical signiﬁcant differences
(P< 0.001) between wt and SPARKI mice after androgen exposure (testosterone) are indicated by stars above the lines, and statistically signiﬁcant
differences (P< 0.001) between testosterone- and vehicle-treated wt or SPARKI mice are depicted by asterisks above the black bar (testosterone)
adjacent to the corresponding white bar (vehicle). (B) ChIP-seq tracks illustrating AR binding at genomic loci adjacent to the androgen-regulated
Arrdc2 and Pkd2l1 genes in wt and SPARKI epididymis. (C) Relative mRNA levels, as measured by qRT-PCR, for androgen-regulated genes
expressed to the same level (stable) in epididymides of intact wt and SPARKI mice. Castrated male mice were treated with testosterone or vehicle for
3 days. (Mean+SEM values, n=5). Statistical signiﬁcant differences (P< 0.001) between testosterone- and vehicle-treated groups are depicted by
asterisks above the black bar (testosterone) adjacent to the corresponding white bar (vehicle). (D) ChIP-seq tracks showing AR loading onto genomic
loci adjacent to the androgen-regulated Lipg and Creld2 genes in wt and SPARKI epididymides.
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Pioneer factors have been reported to guide lineage-, cell-
type- and tissue-speciﬁc AR binding (5,11,30), and the
interplay between steroid receptors and pioneer factors
is likely to contribute to the speciﬁcity of steroid
receptor binding in addition to the DNA–DBD inter-
action. However, we did not ﬁnd markedly dissimilar
compilations of cis-elements for other transcription
factors adjacent to the three ARE categories that would
explain their divergent receptor binding properties
(Supplementary Data set S10).
The determinants of preferential in vivo binding of
SPARKI AR to a subset of ARBs remain elusive. The
DNA sequence in itself may act as an allosteric ligand
for nuclear receptors, thereby affecting receptor conform-
ation and activity (31). However, it is unlikely that this
phenomenon is the main reason for the presence of
SPARKI AR-preferred ARBs in vivo, as the SPARKI
AR sites contain the same ARE sequence as the shared
sites. Moreover, the cis-elements of SPARKI AR-
preferred ARBs in isolation, i.e., in EMSA experiments
and reporter gene assays (cf. Figure 4), lost their selectivity
and responded equally well to wt AR and GR, supporting
the importance of local chromatin environment.
Differences in local chromatin structure, such as histone
and DNA modiﬁcations, could explain the occurrence of
these sites (32). Finally, in addition to cis-elements, cross-
talk of steroid receptors with tissue-speciﬁc pioneer factors
and/or coregulators is likely to inﬂuence receptor recruit-
ment to selected chromatin sites and determine the ﬁnal
transcriptional outcome.
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